Influence of MK-801 post-treatment on neurological and histopathological outcome in experimental spinal cord ischaemia

Biologia

Volumn 52, Issue 6, 1997, Pages 783-788

  Saganoyá, Kamila ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

Author keywords

Cell stamps suppressive; Mk 801 post treatment; Nanta method; Rabbit; Spinal cord ischaemia

Indexed keywords

ANIMALIA; ORYCTOLAGUS CUNICULUS; VIOLA (ANGIOSPERM);

EID: 0346629658     PISSN: 00063088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. BACKHAUSS, C., KARKOUTLY, CH., WELSCH, M. & KRIEGLSTEIN, J. 1992. A mouse model of focal cerebral ischemia for screening neuroprotective drug effects. J. Pharmacol. Meth. 27: 27-32.
2. BUCHAN, A. M., SLIVKA, A. & NUE, D. 1992. The effect of teh NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res. 574: 171-177.
3. CHOI, D. W. 1990. Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonist. Stroke 219: (Suppl. II): 20-22.
4. DE GIROLAMI, U. & ZIVIN, J. A. 1982. Neuropathology of experimental spinal cord ischemia in the rabbit. J. Neuropath. Exp. Neurol. 41: 129-149.
5. DESZI, L., GREENBERG, J. H., HAMAR, J., SLADKY, J., KARP, A. & REIVICH, M. 1992. Acute improvement in histological outcome by MK-801 following focal cerebral ischemia and reqerfusion in the cat independent of blood flow changes. J. Cereb. Blood Flow Metab. 12: 390-399.
6. DIRNAGL, U., TANABE, J. & PULSINELLI, W. 1990. Pre and post-treatment with MK-801 but not pretreatment alone reduces neocortical damage after total cerebral ischcemia in the rat. Exp. Neurol. 108: 232-240.
7. FADEN, A. L. & SIMON, R. P. 1988. A potential role for excitotoxins in the pathophysiology of spinal cord injury. Ann. Neurol. 23: 623-626.
8. FERČÁKOVÁ, A., HALAT, G., MARŠALA, M., LYKA COVÁ N. & MARŠALA, J. 1992. Graded postis chemic reoxygenation reduces lipid peroxidation and reperfusion injury in the rabbit spinal cord Brain Res. 593: 159-167.
9. GARDNER, V. O., CAIOZZO, V. J., MUNDEN, S. K. & BRIDGES, R. J. 1990. Excitotoxins can produce protein degradation in the spinal cord. Spine 15: 858-863.
10. HAO, J. X., NU, X, J., ALDSKOGIUS, H., SEIOGITS, A. & WIESENFELD-HALLIN, Z. 1994. The excitatory amono acid receptor antagonist MK-801 prevents the hypersensitivity induced by spinal cord ischemia in the rat. Exp. Neurol. 113: 182-191.
11. HATTORI, H., MORIN, A. M., SCHWARTZ, P. H., P. JIKAWA, D. G. & WASTERLEIN, C. G. 1989: Posthy poxic treatment with MK- Reduces hypoxic-schemia damage in the nionatal rat. Neurology 39: 713-718.
12. JACOBS, T. P., SHOHAMI, E., BAZE, W., BURUAKE, E., GUNDERSON, C., HALLENBECK, J. M. & DIURSTEIN, G. 1987. Deteriorating storke modes histopathology edema and ejrosanoid changes for lowing spinal cord ischemia in rabbits. Strokes 18: 741-750.
13. KOCHHAR, A., ZIVIN, J. N., LYDEN, P. D. & MAZ ZABELLA, V. 1988. Glutamate antagonist therapy reduces neurologic deficits produced by focal central nervous system ischemia. Arch Neurol 45: 148-153.
14. LANIER, W. L., PERKINS, W. J., KARLSSON, B. R., MILDE, J. J., SCHEITHAUER, B. W., SHEARMAN, C. T. & MICHENFELDER, J. D. 1990. The effects of dizocilpine maleate (MK-801), an antagonist of theN-methyl-D-aspartate receptor, on neurologic recovery and histopathology following complete cerebral ischemia in primates. J. Cereb. Blood Flow Metab. 10: 252-261.
15. LIN, B., DIETRICH. D., GINSBERG, M. D., GLOBUS. M. Y. T. & BUSTO, R. 1993. MK-801 (dizocilpine) protects the brain from repeated normothermic global ischemic insults in the rat. J. Cereb. Blood Flow Metab. 13: 925-932.
16. MALATOVÁ, Ž. & MARŠALA, J. 1993. Cholinergic enzymes in spinal cord infarction. Mol. Chem. Neuropath. 19: 283-286.
17. MARŠALA, M., VANICKÝ. I., RADOŇÁK, J., KLIESENBAUEROVÁ, E. & MARŠALA, J. 1992. Postischemia enhances vulnerability in the rabbit spinal cord ischemia model. Restor. Neurol. Neurosci. 3: 283-291.
18. MARTINEZ-ARIZALA, A., RIGAMONTI, D. D., LONG, J. B., KRAIMER, J. & HOLADAY, J. W. 1990. Effects of NMDA receptor antagonists following spinal ischemia in the rabbit. Exp. Neurol. 108: 252-240.
19. MARTINIAK, J., SAGANOVÁ, K. & CHAVKO, M. 1991. Free and peptide-bound ammo acids as indicators of ischemic damage of the rabbit spinal cord. J. Neuropathol. Exp. Neurol. 50: 73-81.
20. MOORE, W. M. & HOLLIER, L. H. 1991. The influence of severity of spinal cord ischemia in the etiology of delayed-onset paraplegia. Ann. Surgery 213: 427-432.
21. NAUTA. W. J. H. 1957. Silver impregnation of degenerating axons, pp. 17-26. In: Windle, W. F. (eds). New Research Techniques of Neuroanatomy. Thomas, Springfield, IL.
22. OLNEY. J. W. 1994. Neurotoxicity of NMDA receptor antagonist: An overview. Psychopharmacol. Bull. 30: 533-540.
23. ROTHMAN, S. M. & OLNEY, J. W. 1986. Glutamate and the pathophysiology of hypoxic-ischemic brain damage. Ann.Neurol. 19: 105-111.
24. PARK, C. K., NEHLS, D. G., GRAHAM, D. I., TESADALE, G. M. & MCCULLOCH, J. 1988. The glutamate antagonist MK-801 reduces focal ischemic brain damage in the rat. Ann. Neurol. 24: 543-551.
25. REXED, B. 1952. The cytoarchitectonic organization of the spinal cord in the cat. J. Comp. Neurol. 96: 415-495.
26. REXED, B. 1954. A cytoarchitectonic atlas of the spinal cord in the cat. J. Comp. Neurol. 100: 297-379.
27. SAGANOVÁ, K. & MARŠALA, M. 1994. Intrathecal administration of dizocilpine maleate (MK-801) attenuates ischemic damage in the rabbit spinal cord. Exp. Neurol. 130: 337-343.
28. SAGANOVÁ, K. & MARŠALA, J. 1995: Effect of a single dose of MK-801 on delayed neuropathological changes after spinal cord ischaemia. Biologia, Bratislava 50: 303-307.
29. STEWART, G. R., OLNEY, J.W., PATHICONDA. M. & SNIDER. W. D. 1991. Excitotoxicity in the embryonic chick spinal cord. Ann. Neurol. 30: 758-766.
30. YUM, S. W. & FADEN, A. I. 1990. Comparison of the neuroprotective effects of the N-methyl-D-aspartate antagonist MK-801 and the opiate-receptor antagonist nalmefene in experimental spinal cord ischemia. Arch. Neurol. 47: 277-281.
31. ZIVIN, J. 1989. Therapy of embolie stroke with tissue plasminogen activator phis glutamate antagonist. Neurology (Suppl. 1) 39: 39.
32. ZIVIN, J. A. & DE GIROLAMI, U. 1980. Spinal cord infarction: a highly reproducible stroke model. Stroke 11: 200-202.